1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. MMP
  4. MMP Inhibitors

MMP Inhibitors

MMP-1

MMP-2

MMP-3

MMP-8

MMP-9

MMP-13

MMP-14

MMP-17

ADAM10

ADAM17

MMP-7

MMP-12

MMP-10

MMP

ADAM8

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

MMP Inducers, Inhibitors, Agonists, Activators & Chemicals
Product Name MMP-1 MMP-2 MMP-3 MMP-8 MMP-9 MMP-13 MMP-14 MMP-17 ADAM10 ADAM17 MMP-7 MMP-12 MMP-10 MMP ADAM8 Purity
Ilomastat
Fibroblast collagenase, Ki: 0.4 nM (Human skin)
MMP-1, IC50: 1.5 nM
MMP-2, IC50: 1.1 nM
MMP-3, IC50: 1.9 nM
 
MMP-9, IC50: 0.5 nM
                    98.33%
Chloramphenicol          
MMP13
                  99.82%
KP-457  
MMP2, IC50: 717 nM
MMP3, IC50: 9760 nM
MMP8, IC50: 2200 nM
MMP9, IC50: 5410 nM
MMP13, IC50: 930 nM
MMP14, IC50: 2140 nM
MMP17, IC50: 7100 nM
ADAM10, IC50: 748 nM
ADAM17, IC50: 11.1 nM
          99.18%
Astragaloside IV  
MMP-2
   
MMP-9
                    ≥98.0%
Cordycepin
MMP-1
 
MMP-3
                        99.17%
Marimastat
MMP-1, IC50: 5 nM
MMP-2, IC50: 6 nM
MMP-3, IC50: 3 nM
     
MMP-14, IC50: 9 nM
     
MMP-7, IC50: 13 nM
        ≥98.0%
Salvianolic acid A        
MMP-9
                    99.72%
Meloxicam  
MMP-2
                          99.70%
SB-3CT  
MMP-2, Ki: 13.9 nM
   
MMP-9, Ki: 600 nM
                    99.59%
GW280264X                
ADAM10, IC50: 11.5 nM
ADAM17, IC50: 8 nM
          98.28%
MMP-9-IN-1        
MMP-9
                    99.71%
Aderbasib                
ADAM10
ADAM17
          98.09%
TAPI-2                          
MMP, IC50: 20 μM
  99.46%
Tranexamic acid
MMP-1
                            ≥98.0%
Indinavir sulfate  
MMP-2
                          99.96%
Isofraxidin                    
MMP-7
        99.00%
ARP-100
MMP-1, IC50: >50 μM
MMP-2, IC50: 12 nM
MMP-3, IC50: 4.5 μM
 
MMP-9, IC50: 0.2 μM
         
MMP-7, IC50: >50 μM
        ≥99.0%
Prinomastat
MMP-1, IC50: 79 nM
MMP-2, Ki: 0.05 nM
MMP-3, IC50: 6..3 nM
MMP-3, Ki: 0.3 nM
 
MMP-9, IC50: 5 nM
MMP-9, Ki: 0.26 nM
                    ≥98.0%
Auraptene  
MMP-2
                          99.86%
Cetrimonium bromide  
MMP-2
   
MMP-9
                    ≥98.0%
FSL-1 TFA        
MMP-9
                    99.76%
Lixisenatide
MMP-1
 
MMP-3
   
MMP13
                  99.93%
UK 356618
MMP-1, IC50: 51 μM
MMP-2, IC50: 1.79 μM
MMP-3, IC50: 5.9 nM
 
MMP-9, IC50: 0.84 μM
MMP-13, IC50: 73 nM
MMP-14, IC50: 1.9 μM
                98.91%
PD-166793
MMP-1, IC50: 6.0 μM
MMP-2, IC50: 4 nM
MMP-3, IC50: 7 nM
 
MMP-9, IC50: 7.9 μM
MMP-13, IC50: 8 nM
       
MMP-7, IC50: 7.2 μM
        99.45%
Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2
MMP-1, Km: 27.5 μM
       
MMP-13, Km: 5.2 μM
MMP-14, Km: 7.9 μM
                99.87%
Morroniside  
MMP2
   
MMP9
                    98.55%
PF-00356231 hydrochloride    
MMP-3, IC50: 0.39 μM
MMP-8, IC50: 1.7 μM
MMP-9, IC50: 0.98 μM
MMP13, IC50: 0.65 nM
         
MMP-12, IC50: 1.4 μM
      99.52%
Ginkgolide C        
MMP-9
                    ≥98.0%
PPNDS tetrasodium                
ADAM10, IC50: 1.2 μM
           
Cynaropicrin          
MMP13
                  99.71%
DB04760          
MMP-13, IC50: 8 nM
                  99.33%
Isoliquiritin apioside        
MMP9
                    99.87%
Anethole        
MMP-9
                    99.78%
β-Neo-Endorphin  
MMP-2
   
MMP-9
                    98.22%
Hepcidin-1 (mouse) (TFA)        
MMP-9
                    98.94%
MMP-7-IN-1                    
MMP-7, IC50: 10 nM
        99.68%
S 3304        
MMP-9
                    99.11%
SM-7368        
MMP-9
                    99.90%
YH-306  
MMP2
   
MMP9
                    98.01%
MMP3 inhibitor 1
MMP-1, IC50: 14000 nM
MMP-2, IC50: 529 nM
MMP-3, IC50: 1 nM
 
MMP-9, IC50: 2420 nM
 
MMP-14, IC50: 20100 nM
                99.03%
Cipemastat
collagenases 1, Ki: 3.0 nM
gelatinase A, Ki: 154 nM
stromelysins 1, Ki: 527 nM
collagenases 2, Ki: 4.4 nM
gelatinase B, Ki: 59.1 nM
collagenases 3, Ki: 3.4 nM
                  99.81%
JG26      
MMP-8, IC50: 240 nM
MMP-9, IC50: >500000 nM
MMP-9, IC50: 1630 nM
 
MMP14, IC50: 19500 nM
 
ADAM10, IC50: 150 nM
ADAM17, IC50: 1.9 nM
 
MMP-12, IC50: 9.4 nM
   
ADAM8, IC50: 12 nM
98.01%
Imidapril hydrochloride        
MMP-9
                    99.80%
UK-370106  
MMP-2, IC50: 34.2 μM
MMP-3, IC50: 23 nM
MMP-8, IC50: 1.75 μM
MMP-9, IC50: 30.4 μM
MMP-13, IC50: 2.3 μM
MMP-14, IC50: 66.9 μM
     
MMP-7, IC50: 5.8 μM
MMP-12, IC50: 42 nM
      ≥99.0%
PI3K/AKT-IN-2  
MMP-2
                          98.10%
MMP2-IN-1  
MMP2, IC50: 6.8 μM
                          99.18%
NFF-3 TFA    
MMP-3
                 
MMP-10
    98.57%
MMP-2 Inhibitor I  
MMP-2, Ki: 1.7 μM
                          99.23%
MMP-1-IN-1
MMP-1, IC50: 0.034 μM
                            99.10%
Otaplimastat                          
MMP
  98.41%
CTTHWGFTLC, CYCLIC TFA  
MMP-2
   
MMP-9
                    98.60%
Prinomastat hydrochloride
MMP-1, IC50: 79 nM
MMP-2, Ki: 0.05 nM
   
MMP-9, IC50: 5 nM
MMP-9, Ki: 0.26 nM
MMP-13, IC50: 6.3 nM
MMP-13, Ki: 0.3 nM
                  98.18%
Mca-PLAQAV-Dpa-RSSSR-NH2 TFA                
ADAM10
ADAM17
          99.21%
BI-4394  
MMP-2, IC50: 18 μM
   
MMP-9, IC50: 8.9 μM
MMP-13, IC50: 1 nM
MMP-14, IC50: 8.3 μM
         
MMP-10, IC50: 16 μM
    99.91%
MMP13-IN-2  
MMP-2, IC50: 180 nM
MMP-3, IC50: 1100 nM
   
MMP-13, IC50: 0.036 nM
                  99.85%
CMC2.24
MMP-1, IC50: 69.8 μM
MMP-2, IC50: 4.8 μM
MMP-3, IC50: 2.9 μM
MMP-8, IC50: 4.5 μM
MMP-9, IC50: 8 μM
MMP-13, IC50: 2.7 μM
MMP-14, IC50: 15.3 μM
     
MMP-7, IC50: 5 μM
MMP-12, IC50: 2 μM
     
Tanomastat  
MMP-2, Ki: 11 nM
MMP-3, Ki: 143 nM
 
MMP-9, Ki: 301 nM
MMP-13, Ki: 1470 nM
                  ≥99.0%
cis-ACCP  
MMP-2, IC50: 4 μM
   
MMP-9, IC50: 20 μM
                   
MMPI-1154
MMP-1, IC50: 10 μM
MMP-2, IC50: 6.6 μM
   
MMP-9, IC50: 13 μM
MMP-13, IC50: 1.8 μM
                  99.87%
MMP2-IN-3  
MMP-2, IC50: 31 ± 5 μM
 
MMP-8, IC50: 32 ± 4 μM
MMP-9, IC50: 26.6 ± 2.3 μM
MMP-13, IC50: >100 μM
                  99.64%
Hepcidin-1 (mouse)        
MMP-9
                   
MMP-9/10-IN-2                        
MMP-10, IC50: 0.076 μM
   
Imidapril        
MMP-9
                    ≥99.0%
MMP-9/MMP-13 Inhibitor I
MMP-1, IC50: 43 nM
 
MMP-3, IC50: 23 nM
 
MMP-9, IC50: 0.9 nM
MMP-13, IC50: 0.9 nM
       
MMP-7, IC50: 931 nM
        99.90%
MMP2-IN-2  
MMP-2, IC50: 4.2 ± 0.2 μM
 
MMP-8, IC50: 25 ± 10 μM
MMP-9, IC50: 23.3 ± 10. μM
MMP13, IC50: 12 ± 7 μM
                  98.80%
MMP-7-IN-2  
MMP-2, IC50: 33000
MMP-3, IC50: >100000
MMP-8, IC50: >100000
MMP-9, IC50: >100000
MMP-13, IC50: >100000
MMP-14, IC50: 11000 nM
     
MMP-7, IC50: 16 nM
MMP-12, IC50: 12000 nM
      99.34%
ND-336  
MMP-2, Ki: 85 nM
   
MMP-9, Ki: 150 nM
 
MMP-14, Ki: 120 nM
               
Indinavir  
MMP-2
                         
TP0597850  
MMP2, IC50: 0.22 nM
     
MMP13, IC50: 240 nM
         
MMP-12, IC50: 250 nM
      99.09%
FFAGLDD        
MMP9
                   
MMP-2 Inhibitor II
MMP-1, Ki: 45 μM
MMP-2, Ki: 2.4 μM
               
MMP-7, Ki: 379 μM
       
(R)-ND-336  
MMP-2, Ki: 127 nM
   
MMP-9, Ki: 19 nM
 
MMP-14, Ki: 119 nM
               
Mca-Pro-Leu-Ala-Cys(Mob)-Trp-Ala-Arg-Dap(Dnp)-NH2            
MMP-14
               
Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2
MMP-1
 
MMP-3
                       
CP-471474
MMP-1, IC50: 1170 nM
MMP-2, IC50: 0.7 nM
MMP-3, IC50: 16 nM
 
MMP-9, IC50: 13 nM
MMP-13, IC50: 0.9 nM
                 
MMP-8 inhibitor-1      
MMP-8
                     
BPHA
MMP-1, IC50: 974 nM
MMP-2, IC50: 12 nM
MMP-3, IC50: >1000 nM
 
MMP-9, IC50: 16 nM
 
MMP-14, IC50: 17 nM
     
MMP-7, IC50: 795 nM
       
MMP-9-IN-5
MMP-1, IC50: 104 nM
MMP-2, IC50: 266 nM
   
MMP-9, IC50: 4.49 nM
MMP-13, IC50: 280 nM
                 
RXP470.1                      
human MMP-12, Ki: 0.2 nM
     
CP-544439
MMP-1, IC50: 420 nM
MMP-2, IC50: 1.6 nM
MMP-3, IC50: 16 nM
MMP-8, IC50: 1.4 nM
MMP-9, IC50: 12 nM
MMP-13, IC50: 0.75 nM
MMP-14, IC50: 7.4 nM
       
MMP-12, IC50: 0.24 nM
     
HNHA  
MMP-2
   
MMP-9
                   
Hydrangenol
MMP-1
 
MMP-3
                       
MMP12-IN-3                      
MMP-12, IC50: 4.9 nM
     
Nudol  
MMP-2, Ki: 988.9 nM
   
MMP-9, Ki: 1.76 μM
                   
MMP-9-IN-4
MMP-1, IC50: 41 nM
MMP-2, IC50: 139 nM
   
MMP-9, IC50: 7.46 nM
MMP-13, IC50: 113 nM
                 
Anticancer agent 183        
MMP-9
                   
BR351  
MMP-2, IC50: 4 nM
 
MMP-8, IC50: 2 nM
MMP-9, IC50: 11 nM
MMP13, IC50: 50 nM
                 
TP0556351  
MMP-2, IC50: 0.2 nM
                         
ROCK2-IN-7  
MMP-2
                         
MMP-9-IN-7        
MMP-9, IC50: 0.52 μM
                   
Funalenone
collagenases 1
                           
proMMP-9 selective inhibitor-1        
MMP-9
                   
MMP-9-IN-3
MMP-1, IC50: 447 nM
MMP-2, IC50: 221 nM
   
MMP-9, IC50: 5.56 nM
MMP13, IC50: 295 nM
                 
(Rac)-Tanomastat  
MMP-2, Ki: 11 nM
MMP-3, Ki: 143 nM
 
MMP-9, Ki: 301 nM
MMP-13, Ki: 1470 nM
                 
MMP-2/9-IN-1  
MMP-2, IC50: 56 nM
   
MMP-9, IC50: 38 nM
                   
FFAGLDD TFA        
MMP9
                   
NFF-3    
MMP-3
                 
MMP-10
   
Mca-PLAQAV-Dpa-RSSSR-NH2                
ADAM10
ADAM17
         
AChE-IN-51  
MMP-2, IC50: 724 nM
                         
MMP Inhibitor II
MMP-1, IC50: 24 nM
 
MMP-3, IC50: 18.4 nM
 
MMP-9, IC50: 2.7 nM
         
MMP-7, IC50: 30 nM
       
MMP-13-IN-1          
MMP13, IC50: 16 nM
                 
Dnp-PLGLWA-DArg-NH2 TFA
MMP-1
     
MMP-9
                   
Indinavir sulfate ethanolate  
MMP-2
                         
Anticancer agent 65                          
MMP
 
CL-82198 hydrochloride          
MMP13
                 
XL-784 free base
MMP-1, IC50: 1900 nM
MMP-2, IC50: 0.81 nM
MMP-3, IC50: 120 nM
MMP-8, IC50: 10.8 nM
MMP-9, IC50: 18 nM
MMP-13, IC50: 0.56 nM
                 
CTTHWGFTLC, CYCLIC  
MMP-2
   
MMP-9
                   
WAY-170523
MMP-1, IC50: 10 μM
     
MMP-9, IC50: 945 nM
MMP13, IC50: 17 nM
                 
MMP-9-IN-9
MMP-1, IC50: 1050 nM
     
MMP-9, IC50: 5 nM
MMP-13, IC50: 113 nM